NCT02658188View on ClinicalTrials.gov

Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Restless Legs Syndrome
Interventions
DRUG

ASP8825

Oral

Trial Locations (10)

Unknown

Chiba

Fukuoka

Hokkaido

Hyōgo

Kanagawa

Kyoto

Miyagi

Osaka

Saitama

Tokyo

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY